Turk Robby, Averkamp Benjamin, Hietpas Kayla, Michalek Caleb, Leas Daniel, Odum Susan M, Hamid Nady
Atrium Health Carolinas Medical Center, Charlotte, North Carolina.
Atrium Health Musculoskeletal Institute, Charlotte, North Carolina.
J Bone Joint Surg Am. 2025 Apr 2;107(7):665-677. doi: 10.2106/JBJS.24.00460. Epub 2025 Feb 10.
In recent years, orthopaedic surgeons have attempted to decrease opioid consumption through multimodal pain management. However, a limited effort has been made to eliminate opioids entirely in the perioperative period. The purpose of this study was to compare the efficacy and safety of a novel opioid-free pain management pathway with that of an opioid-containing pathway across 5 common orthopaedic subspecialty surgical procedures.
In a 1:1, unblinded fashion, 315 patients were randomized to a perioperative pain management pathway that was either opioid-free (n = 157) or opioid-containing (n = 158). Pain was measured with a numeric rating scale (NRS) for pain of 0 to 10 at 6 hours, 12 hours, 24 hours (the primary outcome assessing noninferiority), 2 weeks, 6 weeks, and 1 year after the surgical procedure. Data on patient characteristics, deviations from the pain management pathway, morphine milligram equivalents (MME), readmissions, adverse events, and patient-reported outcomes were collected.
There were 315 patients in the final group, with a mean age of 63.6 years. Of the patients in the study, 59.7% were female, 85.7% were White, 12.4% were Black/African-American, 1.0% were Hispanic/Latino, 0.6% were American Indian, and 0.3% were unknown. At 24 hours, the median NRS for pain in the opioid-free group (2 [interquartile range (IQR), 0 to 4]) was statistically noninferior (p < 0.0001) to the opioid-containing group (4 [IQR, 2 to 6]). Pain levels were significantly lower in the opioid-free group than in the opioid-containing group at 12 hours (p = 0.0173) and 2 weeks (p = 0.0003). Pain scores at 6 hours, 6 weeks, and 1 year were similar. Patients in the opioid-free group reported significantly greater comfort at 24 hours (p = 0.0392) and higher satisfaction with pain control (p = 0.0355) at 6 weeks. There were no reported adverse events or unplanned readmissions. Demographic characteristics were similar between the 2 groups.
Across 5 common orthopaedic subspecialty procedures, an opioid-free pain management pathway was safe and effective and provided noninferior pain control at 24 hours compared with the opioid-containing pathway.
Therapeutic Level I . See Instructions for Authors for a complete description of levels of evidence.
近年来,骨科外科医生试图通过多模式疼痛管理来减少阿片类药物的使用。然而,在围手术期完全消除阿片类药物的努力有限。本研究的目的是比较一种新型无阿片类药物疼痛管理途径与含阿片类药物途径在5种常见骨科亚专科手术中的疗效和安全性。
采用1:1非盲法,将315例患者随机分为围手术期疼痛管理途径,其中无阿片类药物组(n = 157)和含阿片类药物组(n = 158)。在手术后6小时、12小时、24小时(评估非劣效性的主要结局)、2周、6周和1年,用数字评分量表(NRS)测量疼痛,范围为0至10。收集患者特征、疼痛管理途径偏差、吗啡毫克当量(MME)、再入院、不良事件和患者报告结局的数据。
最终组有315例患者,平均年龄63.6岁。研究中的患者,59.7%为女性,85.7%为白人,12.4%为黑人/非裔美国人,1.0%为西班牙裔/拉丁裔,0.6%为美国印第安人,0.3%身份不明。在24小时时,无阿片类药物组的疼痛NRS中位数为2(四分位间距[IQR],0至4),在统计学上不劣于含阿片类药物组(4[IQR,2至6])(p < 0.0001)。在12小时(p =